BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dumortier J, Boillot O, Scoazec JY. Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: Past, present and future. World J Gastroenterol 2014; 20(32): 11069-11079 [PMID: 25170196 DOI: 10.3748/wjg.v20.i32.11069]
URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11069.htm
Number Citing Articles
1
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2016; : 1 doi: 10.1007/978-3-319-05543-5_21-1
2
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2017; : 355 doi: 10.1007/978-3-319-07209-8_21
3
François Villeret, Sébastien Dharancy, Domitille Erard, Armand Abergel, Louise Barbier, Camille Besch, Olivier Boillot, Karim Boudjema, Audrey Coilly, Filomena Conti, Christophe Corpechot, Christophe Duvoux, François Faitot, Stéphanie Faure, Claire Francoz, Emiliano Giostra, Jean Gugenheim, Jean Hardwigsen, Marie‐Noëlle Hilleret, Jean‐Baptiste Hiriart, Pauline Houssel‐Debry, Nassim Kamar, Guillaume Lassailly, Marianne Latournerie, Georges‐Philippe Pageaux, Didier Samuel, Claire Vanlemmens, Faouzi Saliba, Jérôme Dumortier. Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survivalLiver International 2022; 42(11): 2428 doi: 10.1111/liv.15385
4
Serag Esmat, Nouman El Garem, Hassan Raslan, Mohamed Elfekki, Gihan A Sleem. Critical Flicker Frequency is Diagnostic of Minimal Hepatic EncephalopathyJournal of Investigative Medicine 2017; 65(8): 1131 doi: 10.1136/jim-2017-000428
5
Farina M Hanif, Zain Majid, Nasir Hassan Luck, Abbas Ali Tasneem, Syed Muddasir Laeeq, Muhammed Mubarak. Revolution in the diagnosis and management of hepatitis C virus infection in current eraWorld Journal of Hepatology 2022; 14(4): 647-669 doi: 10.4254/wjh.v14.i4.647
6
Faisal Alshatti, Sarvee Moosavi, Eric. M. Yoshida, Mark W. Hull. Sexually-transmitted seronegative HCV infection in an HIV-positive post-liver transplant recipient. Case report and review of the literatureJournal of Clinical Virology 2016; 79: 51 doi: 10.1016/j.jcv.2016.04.003
7
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2016; : 1 doi: 10.1007/978-3-319-05543-5_21-2
8
Clifford Akateh, Dmitry Tumin, Eliza W. Beal, Khalid Mumtaz, Joseph D. Tobias, Don Hayes, Sylvester M. Black. Change in Health Insurance Coverage After Liver Transplantation Can Be Associated with Worse OutcomesDigestive Diseases and Sciences 2018; 63(6): 1463 doi: 10.1007/s10620-018-5031-6
9
Narendra S. Choudhary, Neeraj Saraf, Sanjiv Saigal, Amit Rastogi, Prashant Bhangui, Srinivas Thiagrajan, Arvinder S. Soin. Outcome of hepatitis C–related liver transplantation in direct-acting antiviral eraIndian Journal of Gastroenterology 2020; 39(6): 539 doi: 10.1007/s12664-020-01105-z
10
Sanjiv Saigal, Narendra S. Choudhary, Neeraj Saraf, Dheeraj Gautam, Lipika Lipi, Amit Rastogi, Sanjay Goja, P. Balachandran Menon, Prashant Bhangui, Sumana K. Ramachandra, Arvinder S. Soin. Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantationIndian Journal of Gastroenterology 2015; 34(4): 305 doi: 10.1007/s12664-015-0578-z
11
Kelsey L. Hawkins, Ives Hot. Retrospective Cohort Study: Ledipasvir-Sofosbuvir With/Without Ribavirin for Chronic Hepatitis C Post–Liver Transplant in a Real-World PopulationJournal of Pharmacy Technology 2018; 34(5): 199 doi: 10.1177/8755122518782478
12
Jérôme Dumortier, Olivier Boillot. Spontaneous Hepatitis C Virus Clearance in a Liver Transplant Recipient After Conversion From Tacrolimus to EverolimusExperimental and Clinical Transplantation 2022; 20(9): 883 doi: 10.6002/ect.2022.0168
13
Fredrik Åberg, Arno Nordin, Leena Toivonen, Helena Isoniemi. Early Predictors of Long-term Outcomes of HCV-negative Liver Transplant Recipients Having Survived the First Postoperative YearTransplantation 2016; 100(2): 382 doi: 10.1097/TP.0000000000001038
14
B.-H. Jung, J.-I. Park, S.-G. Lee. Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case ReportTransplantation Proceedings 2018; 50(9): 2877 doi: 10.1016/j.transproceed.2018.03.057
15
Liat Mlynarsky, Yoram Menachem, Oren Shibolet. Treatment of hepatocellular carcinoma: Steps forward but still a long way to goWorld Journal of Hepatology 2015; 7(3): 566-574 doi: 10.4254/wjh.v7.i3.566
16
Carlo Sposito, Alessandro Cucchetti, Vincenzo Mazzaferro. Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular CarcinomaDigestive Diseases and Sciences 2019; 64(4): 1001 doi: 10.1007/s10620-019-05538-1
17
Narendra S. Choudhary, Sanjiv Saigal, Dheeraj Gautam, Neeraj Saraf, Amit Rastogi, Sanjay Goja, Prashant Bhangui, Arvinder S. Soin. Efficacy And Safety of Sofosbuvir Based Regimens For Treatment of Hepatitis C Recurrence After Living Donor Liver Transplantation: An Experience From IndiaJournal of Clinical and Experimental Hepatology 2018; 8(2): 121 doi: 10.1016/j.jceh.2017.08.004
18
Mazen Naga, Mona Amin, Dina Algendy, Ahmed Elbadry, May Fawzi, Ayman Foda, Serag Esmat, Dina Sabry, Laila Rashed, Samia Gabal, Manal Kamal. Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment responseWorld Journal of Gastroenterology 2015; 21(39): 11141-11151 doi: 10.3748/wjg.v21.i39.11141
19
O. Tronina, K. Ślubowska, N. Mikołajczyk-Korniak, E. Komuda-Leszek, R. Wieczorek-Godlewska, B. Łągiewska, M. Pacholczyk, W. Lisik, M. Kosieradzki, M. Durlik. Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature ReviewTransplantation Proceedings 2017; 49(6): 1409 doi: 10.1016/j.transproceed.2017.01.077
20
Living Donor Organ Transplantation2024; : 997 doi: 10.1016/B978-0-443-23571-9.00034-7
21
Jorge Quarleri, M. Victoria Delpino. Molecular mechanisms implicated in SARS-CoV-2 liver tropismWorld Journal of Gastroenterology 2022; 28(48): 6875-6887 doi: 10.3748/wjg.v28.i48.6875